Alexander Zehnder
CEOMale0.0Global Dominance: 0.00%
Alexander Zehnder is the CEO of Curevac, a German biotech company known for its work on mRNA technology. Recently, he was in the news due to Biontech's announcement of its intention to acquire Curevac in a move aimed at combining their strengths in mRNA research and development.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Alexander Zehnder is the CEO of Curevac, quoted regarding the acquisition by Biontech.
mRNA gegen Krebs: Neue Chancen durch ImpfstoffeNeue Zürcher Zeitung·
Switzerland· 2025-11-24
Switzerland· 2025-11-24
Alexander Zehnder is the CEO of Curevac, who emphasized the significance of the transaction for utilizing mRNA technology.
Biontech übernimmt Curevac: deutscher Biotech-PaukenschlagNeue Zürcher Zeitung·Switzerland· 2025-06-12
Switzerland· 2025-06-12